Cart
0
Get 20% Free Customization In This Report
Buy this report from - $3926

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

LI 1671
Pages: 216
Aug 2016 | 13410 Views
face gplus_n
Author's : Deepa Tatkare
Tables: 64
Charts: 93
twit_n pr_n

Medical Implants Market Overview:

Medical Implants Market is expected to garner $116 billion by 2022. Medical implants are medical devices or tissues that are surgically transplanted inside the body. These implants are used to replace or support any damaged body organs to enhance function of any body organ or to detect errors in normal body functioning. These can be either placed permanently or temporarily in human body and can be removed when they are no longer needed. Some of the implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials.

    medical implants market

The report covers the analysis of medical implants market based on product type, biomaterials, and geography. 

Segment Review:

According to the analysis done for each segment, the neurostimulation market was found to be highest growing market which is attributed to rising consumer awareness, innovative technological advancements, increasing neurological disorders in the ageing population, cost-effective products, growing FDA approvals for clinical trials, development of advanced implantable neurostimulation devices, and improved clinical outcomes. Neurostimulators are segmented into deep brain stimulation (DBS), sacral nerve stimulation (SNS), vagus nerve stimulation (VNS), spinal cord stimulation (SCS) and other neurostimulators.

The orthopedic implants grabbed the largest market in accordance to the total shares in world implants market in 2015, primarily due to increasing obesity and a rise in osteoporosis-related fracture amongst all age groups. Furthermore, patients that opt for orthopedic implant surgeries has increased from the age group of under 55 to over 80 years. Along with this, there is an increasing awareness about the benefits of such surgeries on the quality of life, which has led to increased adoption amongst patients especially in developing countries such as India and China. Improving healthcare infrastructure in developing countries has also lead to the growth of orthopedic implant market. New technologies such as creation of patient-specific implants, especially in knee arthroplasty, using 3D technology and sculptural CAD are being developed which have numerous benefits over off-the-shelf implants.

Source: Primary Research, Government Publications, Company Releases, and AMR Analysis

The medical implants market in Germany is growing at a steady pace which is attributed to factors such as the rising incidence of chronic diseases in the country. Germany has one of the highest rates of death due to heart disease, higher even than the United States or the United Kingdom, owing to lifestyle factors such as increasing rate of smoking (average nearly 24.5% of the German population above 15 years of age are smokers, in the age group 18- to 25-year 35.2% are smokers) and rising obesity. Germany spends more on dental services than any other European country apart from Switzerland, which makes it an attractive market for the dental implant industry. 

Growing elderly population and rise in prevalence of chronic diseases

Rising prevalence of chronic diseases coupled with the rapidly aging population worldwide is set to increase the demand for medical implants. According to the National Institutes of Health report, population of people above 65 years was around 524 million in 2010, which is expected to grow to 1.5 billion till 2050, this would be 16% of the total world population. It is estimated that 27% of the Japanese, 16% of the U.S., 24% of the U.K., 17% of the Russian, and 14% of Chinese population will be above 65 years of age by 2020. With age there are increasing incidences of chronic diseases such as cardiovascular disease, neuropathic disorders, old age-related trauma, and osteoarthritis. For instance, according to the American Heart Association, in 2013, in the U.S., 70.2% of men and 70.9% of women in the range of age 60-79 years had cardiovascular disorders.

KEY BENEFITS

  • This report offers the following benefits in particular:
  • An in-depth exposure to the world medical implants market is provided and light is shed on market dynamics that would prove crucial in understanding the market
  • Quantitative analysis of the current market and estimations through 2014-2022 would assist strategists to design business strategies to capitalize on the prevailing opportunities in the market
  • Porter’s Five Forces analysis examines the competitive structure of the world medical implants market and also provides a deeper understanding of the influence factors for market entry and market expansion
  • Pin-point analysis of geographic segments proffers identification of most profitable segments to capitalize on
  • Strategic analysis of the key leaders and their business strategies within the world medical implants market provided would assist stakeholders to make more informed business decisions

MEDICAL IMPLANTS MARKET SEGMENTATION

By Type

  • Orthopedic Implants                    
    • Reconstructive Joint Replacements                
      • Knee Replacement Implants            
      • Hip Replacement Implants            
      • Extremities            
    • Orthobiologics                
    • Trauma & Craniomaxillofacial
  • Cardiovascular Implants                    
    • Pacing Devices                
      • Cardiac Resynchronization Therapy Devices (CRTs)        
        • CRT-P (CRT with pacemaker function)        
        • CRT-D (CRT with pacemaker and ICD function)        
      • Implantable Cardioverter Defibrillators (ICDs)            
        • Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
        • Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)    
    • Stents                
      • Coronary stents            
        • Drug-eluting Stents (DES)        
        • Bare-metal Coronary Stents        
        • Bioabsorbable Stents        
      • Peripheral stents            
        • Iliac         
        • Femoral-Popliteal        
        • Renal        
        • Carotid        
      • Stent-related Implants            
        • Synthetic Grafts        
        • Vena Cava Filters        
    • Structural Cardiac Implants                
      • Mechanical Heart Valves            
      • Implantable Ventricular-assist Devices            
        • Left Ventricular Assist Device (LVAD)    
        • Right Ventricular Assist Device (RVAD)        
        • Biventricular Assist Device (BIVAD)    
  • Spinal Implants                    
    • Interbody Fusion Devices                
    • Thoracolumbar Devices                
    • Cervical Fixation Devices                
    • Spinal Electrical Stimulation                
    • Vertebral Compression Fracture (VCF) Devices                
    • Motion Preservation Devices
  • Neurostimulators                    
    • Deep Brain Stimulation (DBS)                
    • Sacral Nerve Stimulation (SNS)                
    • Vagus Nerve Stimulation (VNS)                
    • Other neurostimulators    
  • Ophthalmic Implants                    
    • Intraocular Lens                
    • Glaucoma Implants                            
  • Dental Implants                    
    • Plate Form Dental Implants                
    • Root Form Dental Implants    
  • Breast Implants                    
  • Facial Implants    

By Material

  • Metallic Biomaterials                     
  • Ceramic Biomaterials                     
  • Polymers Biomaterials
  • Natural Biomaterials

By Region

  • North America                    
    • U.S.                
    • Canada                
    • Mexic            
  • Europe                    
    • Germany                
    • UK                
    • France                
    • Rest of Europe                
  • Asia-Pacific                    
    • Japan
    • China                
    • India                
    • Rest of Asia-Pacific                
  • LAMEA                    
    • Latin America                
    • Middle East                
    • Africa        
 

Chapter: 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective
2.2 Market beyond what to expect by 2027 ($Million)

2.2.1 Moderate growth scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario

Chapter: 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Porters five forces analysis

3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 High intensity of rivalry
3.3.5 Threat of substitutes

3.4 Top Player Positioning, 2015
3.5 Market dynamics

3.5.1 Drivers

3.5.1.1 Growing elderly population and rise in prevalence of chronic diseases
3.5.1.2 Technological advancements in the field of medical implants
3.5.1.3 Global rise in acceptance of medical implants
3.5.1.4 Improvement of healthcare infrastructure in developing countries
3.5.1.5 Better insurance and reimbursement
3.5.1.6 Increasing Government Focus on Funding R&D Initiatives
3.5.1.7 Rising Number of FDA Approvals for Performing Clinical Trials to Benefit the Market

3.5.2 Restraints

3.5.2.1 High cost of treatment associated with medical implants
3.5.2.2 Stringent approval process as these are highly specialized devices

3.5.3 Opportunities

3.5.3.1 Huge market opportunities in the APAC region and developing countries
3.5.3.2 Increasing awareness amongst patients and increasing preference for a better quality of life
3.5.3.3 Increase in development of minimally invasive and non-surgical procedures

Chapter: 4 WORLD MEDICAL IMPLANTS MARKET, BY PRODUCT

4.1 Overview

4.1.1 Market size and forecast

4.2 Orthopedic implants

4.2.1 Key market trend
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.2.4 Reconstructive joint replacements

4.2.4.1 Market size and forecast
4.2.4.2 Knee replacement implants

4.2.4.2.1 MARKET SIZE AND FORECAST

4.2.4.3 Hip replacement implants

4.2.4.3.1 MARKET SIZE AND FORECAST

4.2.4.4 Extremities

4.2.4.4.1 MARKET SIZE AND FORECAST

4.2.4.5 Orthobiologics

4.2.4.5.1 MARKET SIZE AND FORECAST

4.2.4.6 Trauma & Craniomaxillofacial

4.2.4.6.1 MARKET SIZE AND FORECAST

4.3 Cardiovascular Implants

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.3.4 Pacing devices

4.3.4.1 Market size and forecast
4.3.4.2 Cardiac Resynchronization Therapy Devices (CRTs)

4.3.4.2.1 MARKET SIZE AND FORECAST
4.3.4.2.2 CRT-P (CRT WITH PACEMAKER FUNCTION)
4.3.4.2.3 MARKET SIZE AND FORECAST
4.3.4.2.4 CRT-D (CRT WITH PACEMAKER AND ICD FUNCTION)
4.3.4.2.5 MARKET SIZE AND FORECAST

4.3.4.3 Implantable Cardioverter Defibrillators (ICDs)

4.3.4.3.1 MARKET SIZE AND FORECAST
4.3.4.3.2 TRANS VENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (T-ICDS)
4.3.4.3.3 MARKET SIZE AND FORECAST
4.3.4.3.4 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (S-ICDS)
4.3.4.3.5 MARKET SIZE AND FORECAST
4.3.4.3.6 IMPLANTABLE CARDIAC PACEMAKERS (ICPS)
4.3.4.3.7 MARKET SIZE AND FORECAST

4.3.5 Stents

4.3.5.1 Key market trends
4.3.5.2 Key growth factors and opportunities
4.3.5.3 Market size and forecast
4.3.5.4 Coronary Stents

4.3.5.4.1 MARKET SIZE AND FORECAST
4.3.5.4.2 DRUG-ELUTING STENTS (DES)
4.3.5.4.3 MARKET SIZE AND FORECAST
4.3.5.4.4 BARE-METAL CORONARY STENTS
4.3.5.4.5 MARKET SIZE AND FORECAST
4.3.5.4.6 BIOABSORBABLE STENTS
4.3.5.4.7 MARKET SIZE AND FORECAST

4.3.5.5 Peripheral stents

4.3.5.5.1 MARKET SIZE AND FORECAST
4.3.5.5.2 ILIAC STENT-GRAFTS
4.3.5.5.3 MARKET SIZE AND FORECAST
4.3.5.5.4 FEMORAL-POPLITEAL STENTS
4.3.5.5.5 MARKET SIZE AND FORECAST
4.3.5.5.6 RENAL & RELATED STENTS
4.3.5.5.7 MARKET SIZE AND FORECAST
4.3.5.5.8 CAROTID STENTS
4.3.5.5.9 MARKET SIZE AND FORECAST

4.3.5.6 Stent-related implants

4.3.5.6.1 MARKET SIZE AND FORECAST
4.3.5.6.2 SYNTHETIC GRAFTS
4.3.5.6.3 MARKET SIZE AND FORECAST
4.3.5.6.4 VENA CAVA FILTERS
4.3.5.6.5 MARKET SIZE AND FORECAST

4.3.6 Structural Cardiac Implants

4.3.6.1 Market size and forecast
4.3.6.2 Mechanical heart valves

4.3.6.2.1 MARKET SIZE AND FORECAST

4.3.6.3 Implantable Ventricular-assist devices

4.3.6.3.1 MARKET SIZE AND FORECAST

4.3.6.4 Left Ventricular Assist Device (LVAD)

4.3.6.4.1 MARKET SIZE AND FORECAST

4.3.6.5 Right Ventricular Assist Device (RVAD)

4.3.6.5.1 MARKET SIZE AND FORECAST

4.3.6.6 Biventricular Assist Device (BIVAD)

4.3.6.6.1 MARKET SIZE AND FORECAST

4.4 Spinal Implants

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast
4.4.4 Interbody fusion devices

4.4.4.1 Market size and forecast

4.4.5 Thoracolumbar devices

4.4.5.1 Market size and forecast

4.4.6 Cervical fixation devices

4.4.6.1 Market size and forecast

4.4.7 Spinal electrical stimulation

4.4.7.1 Market size and forecast

4.4.8 Vertebral compression fracture (VCF) devices

4.4.8.1 Market size and forecast

4.4.9 Motion preservation devices

4.4.9.1 Market size and forecast

4.5 Neurostimulators

4.5.1 Key market trends
4.5.2 Key growth factors and opportunities
4.5.3 Market size and forecast
4.5.4 Deep brain stimulators

4.5.4.1 Market size and forecast

4.5.5 Sacral nerve stimulators

4.5.5.1 Market size and forecast

4.5.6 Spinal cord stimulators

4.5.6.1 Market size and forecast

4.5.7 Vagus nerve stimulators

4.5.7.1 Market size and forecast

4.5.8 Other Neurostimulators

4.5.8.1 Market size and forecast

4.6 Ophthalmic implants

4.6.1 Key market trends
4.6.2 Key growth factors and opportunities
4.6.3 Market size and forecast
4.6.4 Intraocular lens

4.6.4.1 Market size and forecast

4.6.5 Glaucoma implants

4.6.5.1 Market size and forecast

4.7 Dental implants

4.7.1 Key market trends
4.7.2 Key growth factors and opportunities
4.7.3 Market size and forecast
4.7.4 Plate-form dental implants

4.7.4.1 Market size and forecast

4.7.5 Root-form dental implants

4.7.5.1 Market size and forecast

4.8 Facial implants

4.8.1 Key market trends
4.8.2 Key growth factors and opportunities
4.8.3 Market size and forecast

4.9 Breast implants

4.9.1 Key market trends
4.9.2 Key growth factors and opportunities
4.9.3 Market size and forecast

Chapter: 5 WORLD MEDICAL IMPLANTS MARKET, BY BIOMATERIALS

5.1 Overview
5.2 Ceramics biomaterials

5.2.1 Market size and forecast

5.3 Metallic biomaterials

5.3.1 Market size and forecast

5.4 Polymers Biomaterials

5.4.1 Market size and forecast

5.5 Natural biomaterials

5.5.1 Market size and forecast

Chapter: 6 WORLD MEDICAL IMPLANTS MARKET, BY GEOGRAPHY

6.1 Overview

6.1.1 Market size and forecast

6.2 North America

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.2.4 U.S. market size and forecast
6.2.5 Canada market size and forecast
6.2.6 Mexico market size and forecast

6.3 Europe

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.3.4 Germany market size and forecast
6.3.5 France market size and forecast
6.3.6 U.K. market size and forecast
6.3.7 Rest of Europe market size and forecast

6.4 Asia-Pacific

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.4.4 Japan market size and forecast
6.4.5 China market size and forecast
6.4.6 India market size and forecast
6.4.7 Rest of Asia-Pacific market size and forecast

6.5 LAMEA

6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
6.5.4 Latin America market size and forecast
6.5.5 Middle East market size and forecast
6.5.6 Africa market size and forecast

Chapter: 7 COMPANY PROFILES

7.1 Abbott Laboratories

7.1.1 Company overview
7.1.2 Operating business segments
7.1.3 Business performance
7.1.4 Key strategic moves & developments
7.1.5 SWOT analysis

7.2 Biotronik SE & Co. KG

7.2.1 Company overview
7.2.2 Operating business segments
7.2.3 Key strategic moves & developments
7.2.4 SWOT analysis

7.3 Boston Scientific Corporation

7.3.1 Company overview
7.3.2 Operating business segments
7.3.3 Business performance
7.3.4 Key strategic moves & developments
7.3.5 SWOT analysis

7.4 C. R. Bard, Inc.

7.4.1 Company overview
7.4.2 Operating business segments
7.4.3 Business performance
7.4.4 Key strategic moves & developments
7.4.5 SWOT analysis

7.5 Cardinal Health, Inc.

7.5.1 Company overview
7.5.2 Operating business segments
7.5.3 Business performance
7.5.4 Key strategic moves & developments
7.5.5 SWOT analysis

7.6 Conmed Corporation

7.6.1 Company overview
7.6.2 Operating business segments
7.6.3 Business performance
7.6.4 SWOT analysis

7.7 Globus Medical, Inc.

7.7.1 Company overview
7.7.2 Operating business segments
7.7.3 Business performance
7.7.4 Key strategic moves & developments
7.7.5 SWOT analysis

7.8 Integra Lifesciences Holdings Corporation

7.8.1 Company overview
7.8.2 Operating business segments
7.8.3 Business performance
7.8.4 Key strategic moves & developments
7.8.5 SWOT analysis

7.9 Johnson & Johnson

7.9.1 Company overview
7.9.2 Operating business segments
7.9.3 Business performance
7.9.4 Key strategic moves & developments
7.9.5 SWOT analysis

7.10 LivaNova PLC

7.10.1 Company overview
7.10.2 Operating business segments
7.10.3 Business performance
7.10.4 Key strategic moves & developments
7.10.5 SWOT analysis

7.11 Medtronic plc

7.11.1 Company overview
7.11.2 Operating business segments
7.11.3 Business performance
7.11.4 Key strategic moves & developments
7.11.5 SWOT analysis

7.12 Nuvasive, Inc.

7.12.1 Company overview
7.12.2 Operating business segments
7.12.3 Business performance
7.12.4 Key strategic moves & developments
7.12.5 SWOT analysis

7.13 Smith & Nephew Plc

7.13.1 Company overview
7.13.2 Operating business segments
7.13.3 Business performance
7.13.4 Key strategic moves & developments
7.13.5 SWOT analysis

7.14 St. Jude Medical, Inc.

7.14.1 Company overview
7.14.2 Operating business segments
7.14.3 Business performance
7.14.4 Key strategic moves & developments
7.14.5 SWOT analysis

7.15 Institut Straumann AG.

7.15.1 Company overview
7.15.2 Straumann: Company Snapshot
7.15.3 Business performance
7.15.4 Key strategic moves & developments
7.15.5 SWOT analysis

7.16 Stryker Corporation

7.16.1 Company overview
7.16.2 Operating business segments
7.16.3 Business performance
7.16.4 Key strategic moves & developments
7.16.5 SWOT analysis

7.17 Wright Medical Group N.V.

7.17.1 Company overview
7.17.2 Operating business segments
7.17.3 Business performance
7.17.4 Key strategic moves & developments
7.17.5 SWOT analysis

7.18 Zimmer Biomet Holdings, Inc.

7.18.1 Company overview
7.18.2 Operating business segments
7.18.3 Business performance
7.18.4 Key strategic moves & developments
7.18.5 SWOT analysis

List of Figures

FIG. 1 IMPACT ANALYSIS OF MODERATE GROWTH SCENARIO (20222027)
FIG. 2 IMPACT ANALYSIS OF RAPID GROWTH SCENARIO (20222027)
FIG. 3 IMPACT ANALYSIS OF DIMINISHING GROWTH SCENARIO (2020-2027)
FIG. 4 TOP INVESTMENT POCKETS IN WORLD MEDICAL IMPLANTS MARKET
FIG. 5 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (20142016)
FIG. 6 TOP WINNING STRATEGIES: NATURE & TYPE
FIG. 7 PORTERS FIVE FORCES ANALYSIS
FIG. 8 TOP PLAYER POSITIONING, 2015
FIG. 9 U.S. MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
FIG. 10 CANADA MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
FIG. 11 MEXICO MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
FIG. 12 GERMANY MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
FIG. 13 FRANCE MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
FIG. 14 U.K. MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
FIG. 15 REST OF EUROPE MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
FIG. 16 JAPAN MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
FIG. 17 CHINA MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
FIG. 18 INDIA MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
FIG. 19 REST OF ASIA-PACIFIC MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
FIG. 20 LATIN AMERICA MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
FIG. 21 MIDDLE EAST MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
FIG. 22 AFRICA MEDICAL IMPLANTS MARKET, (20142022) ($MILLION)
FIG. 23 ABBOTT: REVENUE, 2013-2015, ($MILLION)
FIG. 24 ABBOTT: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 25 ABBOTT: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 26 ABBOTT: SWOT ANALYSIS
FIG. 27 BIOTRONIK- SWOT ANALYSIS
FIG. 28 BOSTON SCIENTIFIC: REVENUE, 20132015 ($MILLION)
FIG. 29 BOSTON SCIENTIFIC: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 30 BOSTON SCIENTIFIC: REVENUE, BY SUBSEGMENT, 2015 (%)
FIG. 31 BOSTON SCIENTIFIC: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 32 BOSTON SCIENTIFIC: SWOT ANALYSIS
FIG. 33 C. R. BARD: REVENUE, 20132015 ($MILLION)
FIG. 34 C. R. BARD: REVENUE, BY PRODUCT TYPE CATEGORY, 2015 (%)
FIG. 35 C. R. BARD: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 36 C. R. BARD - SWOT ANALYSIS
FIG. 37 CARDINAL HEALTH: REVENUE, 20132015 ($MILLION)
FIG. 38 CARDINAL HEALTH: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 39 CARDINAL HEALTH: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 40 CARDINAL HEALTH: SWOT ANALYSIS
FIG. 41 CONMED: REVENUE, 20132015 ($MILLION)
FIG. 42 CONMED: REVENUE, BY PRODUCT TYPE CATEGORY, 2015 (%)
FIG. 43 CONMED: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 44 CONMED: SWOT ANALYSIS
FIG. 45 GLOBUS MEDICAL: NET SALES, 20132015 ($MILLION)
FIG. 46 GLOBUS MEDICAL: REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
FIG. 47 GLOBUS MEDICAL: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 48 GLOBUS MEDICAL: SWOT ANALYSIS
FIG. 49 INTEGRA LIFESCIENCES: REVENUE, 20132015 ($MILLION)
FIG. 50 INTEGRA LIFESCIENCES: REVENUE, BY PRODUCT TYPE CATEGORY, 2015 (%)
FIG. 51 INTEGRA LIFESCIENCES: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 52 INTEGRA LIFESCIENCES - SWOT ANALYSIS
FIG. 53 J&J: REVENUE, 20132015 ($MILLION)
FIG. 54 J&J: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 55 J&J: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 56 J & J: SWOT ANALYSIS
FIG. 57 LIVANOVA: NET SALES, 20132015 ($MILLION)
FIG. 58 LIVANOVA: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 59 LIVANOVA: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 60 LIVANOVA: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 61 LIVANOVA- SWOT ANALYSIS
FIG. 62 MEDTRONIC: NET SALES, 20132015 ($MILLION)
FIG. 63 MEDTRONIC: REVENUE, BY SEGMENT, 2015 (%)
FIG. 64 MEDTRONIC: CARDIAC AND VASCULAR GROUP REVENUE, BY SUBSEGMENT, 2015 (%)
FIG. 65 MEDTRONIC: SWOT ANALYSIS
FIG. 66 NUVASIVE: REVENUE, 20132015 ($MILLION)
FIG. 67 NUVASIVE: REVENUE, BY PRODUCT TYPE CATEGORY, 2015 (%)
FIG. 68 NUVASIVE: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 69 NUVASIVE: SWOT ANALYSIS
FIG. 70 SMITH & NEPHEW: REVENUE, 20132015 ($MILLION)
FIG. 71 SMITH & NEPHEW: REVENUE, BY PRODUCT TYPE, 2015 (%)
FIG. 72 SMITH & NEPHEW: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 73 SMITH & NEPHEW: SWOT ANALYSIS
FIG. 74 ST. JUDE MEDICAL: NET SALES, 20132015 ($MILLION)
FIG. 75 ST. JUDE MEDICAL: REVENUE, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
FIG. 76 ST. JUDE MEDICAL: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 77 ST. JUDE MEDICAL - SWOT ANALYSIS
FIG. 78 STRAUMANN: REVENUE, 20132015 ($MILLION)
FIG. 79 STRAUMANN: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 80 STRAUMANN: SWOT ANALYSIS
FIG. 81 STRYKER: REVENUE, 20132015 ($MILLION)
FIG. 82 STRYKER: REVENUE, BY SEGMENT, 2015 (%)
FIG. 83 STRYKER: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 84 STRYKER - SWOT ANALYSIS
FIG. 85 WRIGHT- COMPANY SNAPSHOT
FIG. 86 WRIGHT: REVENUE, 20132015 ($MILLION)
FIG. 87 WRIGHT: REVENUE, BY PRODUCT TYPE CATEGORY, 2015 (%)
FIG. 88 WRIGHT: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 89 WRIGHT- SWOT ANALYSIS
FIG. 90 ZIMMER BIOMET: REVENUE, 20132015 ($MILLION)
FIG. 91 ZIMMER BIOMET: REVENUE, BY PRODUCT TYPE CATEGORY, 2015 (%)
FIG. 92 ZIMMER BIOMET: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 93 ZIMMER BIOMET- SWOT ANALYSIS

List of Tables

TABLE 1 WORLD MEDICAL IMPLANTS MARKET, BY MODERATE GROWTH SCENARIO, 2022–2027 ($MILLION)
TABLE 2 WORLD MEDICAL IMPLANTS MARKET, BY RAPID GROWTH SCENARIO, 2022–2027 ($MILLION)
TABLE 3 WORLD MEDICAL IMPLANTS MARKET, BY DIMINISHING GROWTH SCENARIO, 2022–2027 ($MILLION)
TABLE 4 WORLD MEDICAL IMPLANTS MARKET, BY PRODUCT, 2014–2022 ($MILLION)
TABLE 5 WORLD MEDICAL IMPLANTS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 6 WORLD ORTHOPEDIC IMPLANT MARKET, BY TYPE ($MILLIONS), 2014-2022
TABLE 7 WORLD ORTHOPEDIC IMPLANT MARKET, BY GEOGRAPHY ($MILLIONS), 2014-2022
TABLE 8 RECONSTRUCTION JOINT REPLACEMENT MARKET BY TYPE, 2014–2022 ($MILLION)
TABLE 9 WORLD CARDIOVASCULAR IMPLANTS MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 10 WORLD PACING DEVICES MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 11 WORLD CARDIAC RESYNCHRONIZATION THERAPY DEVICES, BY TYPE, 2014–2022 ($MILLION)
TABLE 12 WORLD IMPLANTABLE CARDIOVERTER DEFIBRILLATORS BY TYPE, 2014–2022 ($MILLION)
TABLE 13 WORLD STENTS MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 14 WORLD STENTS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 15 WORLD CORONARY STENTS MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 16 WORLD PERIPHERAL STENTS MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 17 WORLD STENT -RELATED IMPLANTS MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 18 WORLD STRUCTURAL CARDIAC IMPLANTS MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 19 WORLD IMPLANTABLE VADS MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 20 WORLD SPINAL IMPLANTS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 21 WORLD SPINAL IMPLANTS MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 22 WORLD NEUROSTIMULATOR IMPLANTS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 23 WORLD NEUROSTIMULATOR IMPLANTS MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 24 WORLD OPHTHALMIC IMPLANTS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 25 WORLD OPHTHALMIC IMPLANTS MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 26 WORLD DENTAL IMPLANTS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 27 WORLD DENTAL IMPLANTS MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 28 WORLD FACIAL IMPLANT MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 29 WORLD FACIAL IMPLANT MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 30 WORLD BREAST IMPLANT MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 31 WORLD BREAST IMPLANT MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 32 WORLD MEDICAL IMPLANT MARKET, BY MATERIAL, 2014–2022 ($MILLION)
TABLE 33 WORLD MEDICAL IMPLANTS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 34 NORTH AMERICA MEDICAL IMPLANTS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 35 NORTH AMERICA MEDICAL IMPLANTS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 36 EUROPE MEDICAL IMPLANTS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 37 EUROPE MEDICAL IMPLANTS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 38 ASIA-PACIFIC MEDICAL IMPLANTS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 39 ASIA-PACIFIC MEDICAL IMPLANTS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 40 LAMEA MEDICAL IMPLANTS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 41 LAMEA MEDICAL IMPLANTS MARKET, BY REGION 2014-2022 ($MILLION)
TABLE 42 ABBOTT: COMPANY SNAPSHOT
TABLE 43 ABBOTT: OPERATING SEGMENTS
TABLE 44 BIOTRONIK- COMPANY SNAPSHOT
TABLE 45 BIOTRONIK: OPERATING SEGMENTS
TABLE 46 BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 47 C. R. BARD- COMPANY SNAPSHOT
TABLE 48 CARDINAL HEALTH- COMPANY SNAPSHOT
TABLE 49 CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 50 CONMED - COMPANY SNAPSHOT
TABLE 51 GLOBUS MEDICAL- COMPANY SNAPSHOT
TABLE 52 GLOBUS MEDICAL: PRODUCT CATEGORIES
TABLE 53 INTEGRA LIFESCIENCES - COMPANY SNAPSHOT
TABLE 54 INTEGRA LIFESCIENCES: PRODUCT CATEGORY
TABLE 55 J &J: COMPANY SNAPSHOT
TABLE 56 LIVANOVA: - COMPANY SNAPSHOT
TABLE 57 LIVANOVA: OPERATING SEGMENTS
TABLE 58 MEDTRONIC - COMPANY SNAPSHOT
TABLE 59 MEDTRONIC: OPERATING SEGMENTS
TABLE 60 NUVASIVE- COMPANY SNAPSHOT
TABLE 61 SMITH & NEPHEW - COMPANY SNAPSHOT
TABLE 62 ST. JUDE MEDICAL:  COMPANY SNAPSHOT
TABLE 63 ST. JUDE MEDICAL: PRODUCT CATEGORIES
TABLE 64 STRYKER - COMPANY SNAPSHOT
TABLE 65 ZIMMER BIOMET- COMPANY SNAPSHOT

 
 

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

 

Get More Information About This Report

For any queries about purchasing this report, Please fill the form below:

Please input the above text in the input box or click refresh

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts